Provectus Biopharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 228,812 | 0.0545% |
| Individual Insiders | 33,995,611 | 8.1% |
| General Public | 385,297,696 | 91.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 18,500,000 | US$3.6m | 0% | no data | |||
| 6,649,298 | US$1.3m | 0% | no data | |||
| 3,532,980 | US$693.9k | 0% | no data | |||
| 2,677,243 | US$525.8k | 0% | no data | |||
| 1,213,153 | US$238.3k | 0% | no data | |||
| 1,077,409 | US$211.6k | 0% | no data | |||
| 200,000 | US$39.3k | 0% | no data | |||
| 145,528 | US$28.6k | 0% | no data | |||
| 100,000 | US$19.6k | 0% | 0.01% | |||
| 50,000 | US$9.8k | 0% | no data | |||
| 26,620 | US$5.2k | 0% | no data | |||
| 22,000 | US$4.3k | 0% | no data | |||
| 20,000 | US$3.9k | 0% | no data | |||
| 10,191 | US$2.0k | 0% | no data | |||
| 1 | US$0 | 0% | no data |